CLN5
Basic information
Region (hg38): 13:76990660-77019143
Links
Phenotypes
GenCC
Source:
- neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 5 (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 5 (Strong), mode of inheritance: AR
- neuronal ceroid lipofuscinosis 5 (Supportive), mode of inheritance: AR
- neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ceroid lipofuscinosis, neuronal, 5 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Neurologic; Ophthalmologic | 7133332; 1649978; 9662406; 15965709; 15728307; 17607606; 19309691; 20157158; 25359263 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neuronal ceroid lipofuscinosis (43 variants)
- Neuronal ceroid lipofuscinosis 5 (17 variants)
- not provided (4 variants)
- CLN5-related disorder (1 variants)
- Abnormality of metabolism/homeostasis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLN5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 152 | 154 | ||||
missense | 168 | 181 | ||||
nonsense | 17 | 21 | 38 | |||
start loss | 2 | |||||
frameshift | 27 | 35 | 64 | |||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 4 | 13 | 1 | 18 | ||
non coding | 76 | 103 | 13 | 192 | ||
Total | 46 | 74 | 252 | 258 | 13 |
Highest pathogenic variant AF is 0.0000723
Variants in CLN5
This is a list of pathogenic ClinVar variants found in the CLN5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-76991837-A-G | Benign (Jun 14, 2018) | |||
13-76991941-G-C | not specified | Likely benign (Mar 31, 2017) | ||
13-76991944-G-A | not specified • Neuronal ceroid lipofuscinosis 5 | Conflicting classifications of pathogenicity (Feb 23, 2018) | ||
13-76991952-A-C | Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases | Conflicting classifications of pathogenicity (Oct 29, 2023) | ||
13-76991952-A-G | Neuronal ceroid lipofuscinosis 5 | Uncertain significance (Aug 04, 2017) | ||
13-76991953-T-A | Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis | Conflicting classifications of pathogenicity (Jan 03, 2022) | ||
13-76991953-T-C | Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases • CLN5-related disorder | Conflicting classifications of pathogenicity (Jan 28, 2024) | ||
13-76991955-C-T | not specified • Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive • Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases | Benign (Jul 15, 2024) | ||
13-76991956-G-C | not specified | Likely benign (Sep 10, 2014) | ||
13-76991957-C-G | Neuronal ceroid lipofuscinosis | Likely benign (Nov 19, 2022) | ||
13-76991958-C-T | Neuronal ceroid lipofuscinosis • Neuronal ceroid lipofuscinosis 5 | Uncertain significance (Sep 06, 2022) | ||
13-76991958-CGGAACCTGCGCTT-C | Neuronal ceroid lipofuscinosis | Uncertain significance (Mar 11, 2022) | ||
13-76991960-G-A | Neuronal ceroid lipofuscinosis | Likely benign (Apr 15, 2023) | ||
13-76991961-A-T | Neuronal ceroid lipofuscinosis • Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
13-76991965-T-C | Uncertain significance (Jan 31, 2019) | |||
13-76991966-G-A | Neuronal ceroid lipofuscinosis | Likely benign (Mar 27, 2021) | ||
13-76991966-G-C | Neuronal ceroid lipofuscinosis | Likely benign (Mar 09, 2022) | ||
13-76991967-C-A | Neuronal ceroid lipofuscinosis | Uncertain significance (Oct 24, 2022) | ||
13-76991968-G-T | Neuronal ceroid lipofuscinosis | Uncertain significance (Aug 26, 2021) | ||
13-76991969-C-A | Neuronal ceroid lipofuscinosis | Likely benign (Nov 03, 2021) | ||
13-76991969-C-G | Neuronal ceroid lipofuscinosis | Likely benign (Sep 08, 2023) | ||
13-76991970-T-C | Neuronal ceroid lipofuscinosis | Likely benign (Apr 12, 2023) | ||
13-76991971-T-C | Neuronal ceroid lipofuscinosis | Uncertain significance (Sep 27, 2022) | ||
13-76991973-G-C | Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases | Conflicting classifications of pathogenicity (Oct 27, 2022) | ||
13-76991973-G-T | Neuronal ceroid lipofuscinosis | Uncertain significance (Oct 31, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLN5 | protein_coding | protein_coding | ENST00000377453 | 4 | 11858 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.71e-8 | 0.409 | 125699 | 0 | 49 | 125748 | 0.000195 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.123 | 226 | 221 | 1.02 | 0.0000103 | 2629 |
Missense in Polyphen | 68 | 84.975 | 0.80023 | 1029 | ||
Synonymous | 0.671 | 76 | 83.8 | 0.907 | 0.00000393 | 784 |
Loss of Function | 0.846 | 14 | 17.9 | 0.784 | 9.09e-7 | 203 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000498 | 0.000498 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000247 | 0.000237 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane (PubMed:22431521). {ECO:0000269|PubMed:22431521}.;
- Disease
- DISEASE: Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]: A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 5 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269|PubMed:15728307, ECO:0000269|PubMed:16814585, ECO:0000269|PubMed:17607606, ECO:0000269|PubMed:19309691, ECO:0000269|PubMed:20052765, ECO:0000269|PubMed:21990111, ECO:0000269|PubMed:24038957, ECO:0000269|PubMed:24058541, ECO:0000269|PubMed:26342652, ECO:0000269|PubMed:9662406}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.166
Intolerance Scores
- loftool
- 0.287
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.0943
- hipred
- N
- hipred_score
- 0.150
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.386
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cln5
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- signal peptide processing;lysosomal lumen acidification;brain development;neurogenesis;protein catabolic process;retrograde transport, endosome to Golgi;neuron maturation;glycosylation;positive regulation of GTP binding
- Cellular component
- lysosome;lysosomal membrane;endoplasmic reticulum;Golgi apparatus;cytosol;integral component of membrane;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- protein binding;mannose binding